Table 1—

Bacteriological findings of the 122 patients with either probable or definite aetiology of the episode of community-acquired pneumonia

TotalSputumBlood cultureTBASPSB, BALPleural fluidSerology, urinary antigen
Streptococcus pneumoniae 38/204 (19)19/38 (50)17/38 (45)1/38 (50)1/38 (3)
Haemophilus influenzae 12/204 (6)9/12 (75)2/12 (17)1/12 (8)
Moraxella catarrhalis 2/204 (1)1/2 (50)1/2 (50)
Staphylococcus aureus 4/204 (2)3/4 (75)1/4 (25)
Streptococcus viridans 3/204 (2)3/3 (100)
Streptococcus pyogenes 1/204 (0.5)1/1(100)
Pseudomonas aeruginosa 9/204 (4)3/9 (33)1/9 (11)3/3 (33)2/9 (22)
Klebsiella pneumoniae 1/204 (0.5)1/1 (100)
Escherichia coli 4/204 (2)3/4 (75)1/4 (25)
Chlamydia pneumoniae 21/204 (10)21/21 (100)
Chlamydia psittaci 1/204 (0.5)1/1 (100)
Mycoplasma3/204 (2)3/3 (100)
Coxiella3/204 (2)3/3 (100)
Legionella pneumophila 11/204 (5)11/11 (100)
Mycobacterium tuberculosis 1/204 (0.5)1/1 (100)
Aspergillus fumigatus 1/204 (0.5)1/1 (100)
Eikenella corrodens 1/204 (0.5)1/1 (100)
Virus6/204 (3)6/6 (100)
Total204/204 (100)33/122 (27)31/122 (25)8/122 (7)2/122 (2)3/122 (3)45/122 (37)
  • Data are presented as n/total n (%). Percentages in the first column refer to the total number of patients in the study (n=204) to yield comparability to other diagnostics studies on community-acquired pneumonia. Probable: n=33

  • definite: n=89

  • community-acquired pneumonia: n=122

  • TBAS: tracheobronchial aspirate (quantitative bacterial cultures ≥105 colony forming units (cfu)·mL−1)

  • PSB: protected specimen brush (quantitative bacterial cultures ≥103 cfu·mL−1)

  • BAL: bronchoalveolar lavage